TABLE 3.

Evaluation of applications 1–12

#Application description	RI (all scenarios equally weighted)	RI $({\mathbf{R}}_{\mathbf{E}}\mathbf{1}.\mathbf{5})$	$\mathbf{\Sigma }$ of $\mathit{D}98{\%}_{\mathbf{CTV}},$ $\mathbf{\Sigma }$ [Gy]	$\mathbf{\Sigma }$ of $\mathit{D}2{\%}_{\mathbf{CTV}},$ $\mathbf{\Sigma }$ [Gy]	Structure with greatest $\mathbf{\Sigma }$ for mean dose, $\mathbf{\Sigma }$ [Gy]	Structure with greatest $\mathbf{\Sigma }$ for D 2%, $\mathbf{\Sigma }$ Gy]
1. IMRT setup (systematic)	0.8%	2.2%	1.3	0.5	Optic nerve r.: 8.8	Optic nerve r.: 15.1
2. IMRT setup (random)	9.6%	31.3%	0.1	0.1	Chiasma: 1.8	Eye_r.: 2.4
3. VMAT setup (systematic)	8.0%	12.5%	0.5	0.3	Optic nerve r.: 7.3	Optic nerve r.: 14.4
4. VMAT setup (random)	14.4%	49.5%	0.1	0.2	Chiasma: 2.2	Chiasma: 1.8
5. DTRT setup (systematic)	16.8%	23.2%	0.5	0.4	Optic nerve r.: 6.2	Chiasma: 14.5
6. DTRT setup (random)	5.6%	23.4%	0.1	0.1	Optic nerve r.: 0.8	Chiasma: 1.5
7. IMRT MLC/Jaws	21.0%	29.9%	1.7	1.7	PTV: 1.9	Lacrimal gland r.: 1.9
8. DTRT gantry, table, collimator	12.0%	33.5%	0.4	0.3	Lacrimal gland r.: 0.9	Optic nerve r.: 1.5
9. DYMBER electron setup	25.9%	31.2%	0.9	0.7	Lacrimal gland r.: 0.4	PTV: 0.7
10. VMAT rigid intrafraction motion	16.0%	43.2%	0.2	0.8	Chiasma: 0.6	Optic nerve r.: 1.2
11. VMAT, logfile	5.1%	15.3%	0.2	0.2	Chiasma: 1.6	Lacrimal gland l.: 3.5
12. VMAT, systematic and random patient and machine uncertainties	13.9%	16.9	0.1	0.2	Optic nerve r.: 1.6	Chiasma: 3.6

Note: Robustness index (RI) for all scenarios weighted equally and $R_{\mathrm{E}}=1.5$. Standard deviations for $D98{\%}_{\mathrm{CTV}}$ and $D2{\%}_{\mathrm{CTV}}$ and structure with greatest standard deviation in mean dose and D2%. The calculation of standard deviations is based on the default metric and $R_{\mathrm{E}}=1.5$.